News and Analysis

Eli Lilly (NYSE: LLY) won the approval it sought when the FDA authorized the company’s oral obesity drug Foundayo (orforglipron), but the pharma giant’s post-approval

Startup Pinnacle Medicines is developing peptide drugs with the same efficacy as biologic medicines and the dosing convenience of oral small molecules. The lead program

What Makes Non-Human Identity Security Protocols So Crucial? Where increasingly reliant on machine interactions, a critical question emerges for cybersecurity professionals: how do we secure